Medical District Developments, LLC – Trademark Portfolio

Entity Type: 16

Medical District Developments, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 4 Nice Classification classes. The owner is based in Aventura, FL.

2890 NE 214 St

Aventura, FL 33180

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Medical District Developments, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (4 filings)

Advertising; business management; business administration; office functions

36
Insurance & Financial (4 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

43
Hotels & Restaurants (2 filings)

Services for providing food and drink; temporary accommodation

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Medical District Developments, LLC have?

Medical District Developments, LLC has 4 U.S. trademarks filed with the USPTO.

What trademark classes does Medical District Developments, LLC file in?

Medical District Developments, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 43 (Hotels & Restaurants), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What is Medical District Developments, LLC's trademark registration success rate?

Medical District Developments, LLC has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.